Renin-angiotensin blockade in heart failure with preserved ejection fraction: a systematic review and meta-analysis.

about

Targeting atrial fibrillation promoting atrial structural remodeling: is this a viable strategy in patients with heart failure?

P2860

Q48540569-EE4BEE28-AC7E-472D-87A7-5AA238183C35

P2860

Renin-angiotensin blockade in heart failure with preserved ejection fraction: a systematic review and meta-analysis.

Item

http://www.wikidata.org/entity/Q46874079

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Renin-angiotensin blockade in ...... atic review and meta-analysis.

@en

Renin-angiotensin blockade in ...... atic review and meta-analysis.

@nl

type

Item

label

Renin-angiotensin blockade in ...... atic review and meta-analysis.

@en

Renin-angiotensin blockade in ...... atic review and meta-analysis.

@nl

prefLabel

Renin-angiotensin blockade in ...... atic review and meta-analysis.

@en

Renin-angiotensin blockade in ...... atic review and meta-analysis.

@nl

P1476

Renin-angiotensin blockade in ...... atic review and meta-analysis.

@en

P2093

Hassan Khan

http://www.w3.org/2001/XMLSchema#string

Muhammad Shahzeb Khan

http://www.w3.org/2001/XMLSchema#string

Stephen J Greene

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Bias in meta-analysis detected by a simple, graphical test

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

Trends in prevalence and outcome of heart failure with preserved ejection fraction

Outcome of heart failure with preserved ejection fraction in a population-based study

A randomized double-blind trial of enalapril in older patients with heart failure and preserved ejection fraction: effects on exercise tolerance and arterial distensibility.

Irbesartan in patients with heart failure and preserved ejection fraction.

Epidemiology of diastolic heart failure.

Angiotensin receptor blockers and outcomes in real-world older patients with heart failure and preserved ejection fraction: a propensity-matched inception cohort clinical effectiveness study.

Angiotensin-converting enzyme inhibitors and outcomes in heart failure and preserved ejection fraction.

A randomized, double-blind, placebo-controlled study to determine the effects of valsartan on exercise time in patients with symptomatic heart failure with preserved ejection fraction.

P304

402-408

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

meta-analysis

P356

10.1002/EHF2.12204

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P5008

ScienceSource

P577

2017-09-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28869332

http://www.w3.org/2001/XMLSchema#string

P921

heart failure

mechanism of action

P932

5695183

http://www.w3.org/2001/XMLSchema#string

Renin-angiotensin blockade in heart failure with preserved ejection fraction: a systematic review and meta-analysis.

about

P2860

P2860

Renin-angiotensin blockade in heart failure with preserved ejection fraction: a systematic review and meta-analysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P50

P5008

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P50

P5008

P577

P698

P921

P932